626 related articles for article (PubMed ID: 22167414)
1. Modeling human neurodegenerative diseases in transgenic systems.
Gama Sosa MA; De Gasperi R; Elder GA
Hum Genet; 2012 Apr; 131(4):535-63. PubMed ID: 22167414
[TBL] [Abstract][Full Text] [Related]
2. Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases.
Rani N; Alam MM; Jamal A; Bin Ghaffar U; Parvez S
Ageing Res Rev; 2023 Nov; 91():102036. PubMed ID: 37598759
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of APPL mimics transgenic Aβ induced neurodegenerative phenotypes in Drosophila.
Singh SK; Srivastav S; Yadav AK; Srikrishna S
Neurosci Lett; 2017 May; 648():8-13. PubMed ID: 28336338
[TBL] [Abstract][Full Text] [Related]
4. RNAi silencing in mouse models of neurodegenerative diseases.
Farah MH
Curr Drug Deliv; 2007 Apr; 4(2):161-7. PubMed ID: 17456035
[TBL] [Abstract][Full Text] [Related]
5. Towards a transgenic model of Huntington's disease in a non-human primate.
Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW
Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016
[TBL] [Abstract][Full Text] [Related]
6. Genetic neurodegenerative diseases: the human illness and transgenic models.
Price DL; Sisodia SS; Borchelt DR
Science; 1998 Nov; 282(5391):1079-83. PubMed ID: 9804539
[TBL] [Abstract][Full Text] [Related]
7. Transgenic animal models of neurodegeneration based on human genetic studies.
Harvey BK; Richie CT; Hoffer BJ; Airavaara M
J Neural Transm (Vienna); 2011 Jan; 118(1):27-45. PubMed ID: 20931247
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.
Jankowsky JL; Savonenko A; Schilling G; Wang J; Xu G; Borchelt DR
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):457-64. PubMed ID: 12169227
[TBL] [Abstract][Full Text] [Related]
9. From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease.
Shulman JM; Shulman LM; Weiner WJ; Feany MB
Curr Opin Neurol; 2003 Aug; 16(4):443-9. PubMed ID: 12869801
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders.
Koutsilieri E; Rethwilm A; Scheller C
J Neural Transm Suppl; 2007; (72):43-9. PubMed ID: 17982877
[TBL] [Abstract][Full Text] [Related]
11. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
Rockenstein E; Crews L; Masliah E
Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
[TBL] [Abstract][Full Text] [Related]
12. Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs.
Yang D; Wang CE; Zhao B; Li W; Ouyang Z; Liu Z; Yang H; Fan P; O'Neill A; Gu W; Yi H; Li S; Lai L; Li XJ
Hum Mol Genet; 2010 Oct; 19(20):3983-94. PubMed ID: 20660116
[TBL] [Abstract][Full Text] [Related]
13. Transgenic invertebrate models of age-associated neurodegenerative diseases.
Link CD
Mech Ageing Dev; 2001 Sep; 122(14):1639-49. PubMed ID: 11511401
[TBL] [Abstract][Full Text] [Related]
14. lncRNA NEAT1: Key player in neurodegenerative diseases.
Li K; Wang Z
Ageing Res Rev; 2023 Apr; 86():101878. PubMed ID: 36738893
[TBL] [Abstract][Full Text] [Related]
15. Transgenic rat model of Huntington's disease.
von Hörsten S; Schmitt I; Nguyen HP; Holzmann C; Schmidt T; Walther T; Bader M; Pabst R; Kobbe P; Krotova J; Stiller D; Kask A; Vaarmann A; Rathke-Hartlieb S; Schulz JB; Grasshoff U; Bauer I; Vieira-Saecker AM; Paul M; Jones L; Lindenberg KS; Landwehrmeyer B; Bauer A; Li XJ; Riess O
Hum Mol Genet; 2003 Mar; 12(6):617-24. PubMed ID: 12620967
[TBL] [Abstract][Full Text] [Related]
16. Germline transmission in transgenic Huntington's disease monkeys.
Moran S; Chi T; Prucha MS; Ahn KS; Connor-Stroud F; Jean S; Gould K; Chan AW
Theriogenology; 2015 Jul; 84(2):277-85. PubMed ID: 25917881
[TBL] [Abstract][Full Text] [Related]
17. The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review.
Cecerska-Heryć E; Pękała M; Serwin N; Gliźniewicz M; Grygorcewicz B; Michalczyk A; Heryć R; Budkowska M; Dołęgowska B
Cell Mol Neurobiol; 2023 Aug; 43(6):2643-2673. PubMed ID: 37027074
[TBL] [Abstract][Full Text] [Related]
18. Towards Understanding Neurodegenerative Diseases: Insights from
Wu Y; Chen Y; Yu X; Zhang M; Li Z
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203614
[TBL] [Abstract][Full Text] [Related]
19. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
20. Where and Why Modeling Amyotrophic Lateral Sclerosis.
Liguori F; Amadio S; Volonté C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
